Publication-Grade Evidence from Big Data Registries.
ACP Data Lab helps pharmaceutical, medtech, and healthcare teams transform surgical and medical registry data into publication-grade evidence, sharper strategy, and decision-ready insight.
Analysis. Consulting. Prediction.
ACP Data Lab is a medical outcomes research firm that bridges academic medicine and biopharmaceutical strategy.
ACP Data Lab specializes in large-scale registry analytics, turning population-level medical data into actionable intelligence for product positioning, market access, and clinical adoption.
Founded by surgeon-scientists with deep expertise in outcomes research, we combine peer-reviewed methodological rigour with a commercial mindset. Our analyses meet the publication standards of journals including The Lancet, Annals of Surgery, and JAMA Surgery — the same credibility now applied to your commercial challenge.
All research uses de-identified registry data accessed under approved Data Use Agreements from the American College of Surgeons, AHRQ, and NCI. No patient-identifiable data is collected or retained. Methodology is documented to regulatory submission standards and available for independent peer review.
Analysis
Large-scale registry analytics across 945K+ patient records from national surgical databases — de-identified, IRB-compliant, and DUA-governed.
Consulting
Evidence-based strategy for pharmaceutical go-to-market, formulary access, and product differentiation at the medical affairs level.
Prediction
Data-driven forecasting for clinical adoption, complication risk stratification, and market access modelling using validated ML approaches.
Research-Driven Intelligence.
Every deliverable is grounded in peer-reviewed methodology and designed for commercial impact.
Real-World Evidence Development
Large-scale analyses of national surgical registries to generate product-relevant clinical evidence — publishable or white-paper format, designed for regulatory submissions, medical affairs, and payer dossiers.
Market Landscape & Opportunity Sizing
Procedure-level quantification of addressable patient populations, prescribing patterns, and treatment pathway analysis. We identify where your product fits in clinical practice and quantify the commercial opportunity.
Clinical Adoption Strategy
Hospital-level implementation intelligence: decision-maker mapping, protocol framework development, and P&T Committee evidence packages. From registry data to formulary approval.
What Pharmaceutical and Medtech Teams Get From Us.
We answer the specific questions that move products forward — from market access through KOL engagement to formulary approval.
Publication-Ready Evidence
Registry analyses that meet top-tier journal standards — credible to payers, KOLs, and regulators because they were built to survive peer review, not just internal review.
Payer Dossier Support
Population-level evidence on treatment patterns, complication rates, and outcome differentials — structured for formulary submissions and health technology assessments.
Opportunity Quantification
Procedure-level patient volume, prescribing pattern analysis, and hospital-level segmentation — enabling precise resource allocation and field force targeting.
Bridge the gap between data and action.
Valuable surgical data exists everywhere — but is rarely shaped into evidence that can be used quickly, credibly, and strategically.
A Formal Engagement Process.
Each engagement follows a structured protocol — from confidential briefing through delivery of a publication-grade analytical package. Fixed-scope pricing, defined milestones, no open-ended retainers.
Selected Publications.
Representative analyses from our healthcare outcomes research portfolio — each with direct relevance to pharmaceutical strategy and market access.
Scientific Leadership.
Surgeon-scientists and research leaders who understand the methodological standards required for serious healthcare evidence.
Begin a Confidential Engagement.
We work with pharmaceutical, biotechnology and other medical device companies on a project basis. Every engagement begins with a confidential discovery call — no obligation, no commitment until written scope is agreed.
References and prior engagement scope available upon request under NDA.
ACP Data Lab Ltd. · [email protected] · All analyses conducted in compliance with applicable data use agreements and research ethics standards.